Related Experiment Video

Updated: Nov 3, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.9K

The case for AI-driven cancer clinical trials - The efficacy arm in silico

Likhitha Kolla1, Fred K Gruber2, Omar Khalid2

  • 1Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Biochimica Et Biophysica Acta. Reviews on Cancer
|June 3, 2021
PubMed

Insights

In silico trials using causal artificial intelligence (AI) can improve cancer drug development by simulating clinical trials. This approach enhances drug efficacy and patient safety, optimizing precision medicine strategies.

Area of Science:

  • Oncology
  • Computational Biology
  • Artificial Intelligence

Background:

  • Pharmaceutical agents in oncology face high attrition rates in clinical trials.
  • Advances in computational methods and clinico-genomic data enable in silico simulations.
  • In silico trials offer a potential solution to improve traditional clinical trial design.

Purpose of the Study:

  • To review the current and potential applications of in silico trials and causal AI in oncology.
  • To explore how these methods can enhance the efficacy and safety of cancer drug development.
  • To highlight the role of in silico approaches in advancing precision medicine.

Main Methods:

  • Review of existing literature on in silico trials and causal AI in oncology.
  • Discussion of computational methods for simulating drug efficacy in diverse patient populations.
  • Analysis of the integration of clinico-genomic databases with AI for trial simulation.

Main Results:

  • In silico trials can effectively simulate control and efficacy arms of clinical studies.
  • Causal AI can inform crucial aspects of trial design, including patient recruitment and dosage.
  • These computational approaches facilitate subgroup analyses essential for personalized medicine.

Conclusions:

  • In silico trials powered by causal AI represent a significant advancement in oncology drug development.
  • These methods promise to increase the efficiency and success rates of clinical trials.
  • The application of in silico trials is critical for enabling precision medicine in cancer care.
Keywords:
AICausal AIDisease modelingEfficacy armSystems biomedicinein silico clinical trials

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.4K
In Silico Clinical Trials for Cardiovascular Disease09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.9K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.4K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
491
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
797